Sign Up Today and Learn More About ARTHEx Biotech Stock
Invest in or calculate the value of your shares in ARTHEx Biotech or other pre-IPO companies through EquityZen's platform.
ARTHEx Biotech Stock (ARBI)
AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.
About ARTHEx Biotech Stock
Founded
2019
Industries
Science and Engineering, Biotechnology
ARTHEx Biotech Press Mentions
Stay in the know about the latest news on ARTHEx Biotech
Seven miRNA-focused companies pioneering new therapies in 2024
labiotech • Nov 27, 2024
ARTHEx Biotech Announces FDA Rare Pediatric Designation (RPD) of ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
prnewswire • Nov 07, 2024
ARTHEx Biotech Announces FDA Rare Pediatric Designation (RPD) of ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
morningstar • Nov 07, 2024
ARTHEx Biotech Announces Participation in Barclays Biotech: 1x1 Private Company Symposium
prnewswire • Aug 03, 2024
ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES ...
prnewswire • May 19, 2024
ARTHEx Biotech Management
Leadership team at ARTHEx Biotech
CEO, Co-founder
Beatriz LlamusĂ
Board Member
Albert Ferrer
Join now and verify your accreditation status to gain access to:
- ARTHEx Biotech current valuation
- ARTHEx Biotech stock price
- Available deals in ARTHEx Biotech and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in ARTHEx Biotech stock?
Accredited investors can buy pre-IPO stock in companies like ARTHEx Biotech through EquityZen funds. These investments are made available by existing ARTHEx Biotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ARTHEx Biotech stock?
Shareholders can sell their ARTHEx Biotech stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
